Invention Grant
- Patent Title: Anti-SIRPa antibodies and their therapeutic applications
-
Application No.: US16093062Application Date: 2017-04-14
-
Publication No.: US11279766B2Publication Date: 2022-03-22
- Inventor: Nicolas Poirier , Caroline Mary , Bernard Vanhove , Vanessa Gauttier , Virginie Thepenier , Sabrina Pengam
- Applicant: OSE IMMUNOTHERAPEUTICS
- Applicant Address: FR Nantes
- Assignee: OSE IMMUNOTHERAPEUTICS
- Current Assignee: OSE IMMUNOTHERAPEUTICS
- Current Assignee Address: FR Nantes
- Agency: Thompson Coburn LLP
- Agent William A. Holtz
- Priority: EP17305182 20170217
- International Application: PCT/EP2017/059071 WO 20170414
- International Announcement: WO2017/178653 WO 20171019
- Main IPC: C07K16/00
- IPC: C07K16/00 ; A61K39/00 ; A61K38/00 ; C07K16/28 ; A61P35/00 ; G01N33/68
Abstract:
The present invention provides new anti-SIRPa antibodies able to specifically antagonize the interaction between SIRPa and CD47, without affecting the interaction between SIRPg and CD47, and their uses.
Public/Granted literature
- US20190127477A1 NEW ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS Public/Granted day:2019-05-02
Information query
